Otolaryngologist at RAJVITHI CLINIC

Medically reviewed by a board-certified ENT specialist

Author:
Dr. Poj PinyopornpanishOtolaryngologist · Thai Board of Otolaryngology
Medical reviewer:
Dr. Poj PinyopornpanishOtolaryngologist · Thai Board of Otolaryngology
View doctor profile
  • Reviewed on:
  • Last updated:
  • Estimated reading time: 6 min

Skin Prick Test:What Allergies Can It Test and Who Should Consider It?

A skin prick test is a tool for selected immediate allergy questions — not a universal answer for every nasal symptom, and not required in every case.

People with recurrent sneezing, runny nose, congestion, or nasal itch often ask whether they need allergy testing. Skin prick testing (SPT) checks skin responses to suspected allergens. Results must be read with the clinical history; a positive test means sensitization and does not automatically prove that substance causes every symptom.

ALLERGY · DEFINITION

What is a skin prick test?

SPT is a skin-based test looking for immediate hypersensitivity responses to selected allergen extracts.

Trained staff place tiny amounts of test material on the skin — often the forearm — and use a small lancet to puncture the superficial skin so the extract contacts local immune cells.

A relevant response usually appears as a raised wheal with redness within a short time and is measured against controls.

IgE BASICS

How does this relate to IgE immediate allergy?

Many immediate allergic responses involve IgE antibodies that recognize a specific allergen.

When IgE to that allergen is present, skin cells may respond quickly after exposure, producing a wheal during testing.

SPT is therefore useful for selected immediate aeroallergen questions — not for every condition people call “allergy.”

This simple framing helps patients understand that a positive result shows sensitization, not automatic clinical causation.

AEROALLERGENS

Which aeroallergens can it test?

Panels usually focus on aeroallergens linked to everyday nasal and eye symptoms.

In Thailand and northern settings, house dust mites are common and clinically important. Panels may also include locally relevant pollens, molds, animal dander, and cockroach, depending on the clinic set.

Exact panels vary. Clinicians choose extracts that match the patient’s environmental history.

  • House dust mites — often important for bedroom and home exposure
  • Locally relevant pollens — by season and region
  • Molds — sometimes linked to damp environments
  • Animal dander — when pet exposure is relevant
  • Cockroach — an indoor allergen in some settings

PROCEDURE

What happens during the procedure?

After history and basic assessment, if testing is indicated, staff clean the skin, apply extracts, and perform superficial pricks using clinic standards.

Positive and negative controls are usually included so responses can be interpreted correctly.

Patients remain under observation for the clinic’s designated period so results can be read and safety monitored.

INTERPRETATION

What does a positive result mean — and not mean?

A positive result indicates cutaneous sensitization to that extract. It does not automatically prove that allergen causes the patient’s symptoms every time.

Negative results also have limits when history is strongly allergic or when factors blunt skin responses.

Interpretation must combine exposure history and clinical pattern — not test results alone.

Sensitization

  • Skin responds to the extract
  • Suggests relevant IgE tendency
  • Not equal to proven cause

Clinical allergy

  • Real-life symptoms match that exposure
  • History and exam align
  • Used with testing to plan care

A positive test is one data point — the symptom history remains central.

WHO BENEFITS

Who may benefit from testing?

People whose symptoms fit allergic rhinitis and who need targeted avoidance guidance may benefit when results are likely to change care.

Those with chronic or recurrent symptoms and unclear environmental clues may use SPT as part of assessment — not as the first step for every case.

Testing decisions are individualized based on symptoms, readiness, and the clinical question.

WHEN LESS USEFUL

When is testing less useful?

If symptoms do not fit immediate allergy patterns, or the question is not about aeroallergens, testing may not change the plan.

Certain skin conditions or factors that blunt responses can limit interpretation; clinicians may choose alternatives.

Testing is not meant as a routine screen for people without symptoms or without a clear clinical question.

MEDICATIONS

Some medicines can interfere — follow clinic instructions

Certain antihistamines can reduce skin responses and make interpretation harder.

Before a scheduled SPT, share your full medication list and follow the specific instructions from your clinician or clinic.

This article does not give universal stop-drug instructions. Medication changes must consider each person’s conditions, need for therapy, and safety.

Do not stop important medicines on your own based on general online advice. Ask your care team before the visit if unsure.

LIMITS & SAFETY

Limitations and general safety

SPT does not cover every allergy type, does not replace history, and does not diagnose all nasal diseases.

Local itch or wheal at test sites is expected with the method. Systemic reactions are uncommon in general; testing is still done with observation capacity.

Blood specific-IgE testing may be an alternative or complement when skin testing is unsuitable or extra information is needed. Choice depends on clinical context.

HOW RESULTS HELP

How do results guide avoidance and treatment?

When results match the history, clinicians may recommend practical exposure reduction — for example, bedroom measures when dust mites matter.

Findings can also support counseling about therapies more aligned with an allergic mechanism, while severity and comorbidities still guide care.

If results do not fit symptoms, clinicians avoid forcing a label from the test alone and reconsider other nasal drivers such as mucosal swelling, structure, or sinus disease.

SUMMARY

Summary

Skin prick testing helps when the clinical question is clear — and results must be read with history, not used to label everyone as allergic.

SPT assesses immediate responses to selected aeroallergens. A positive result means sensitization, not automatic proof of cause. People who benefit are those for whom results refine avoidance or care planning. Medication issues that may affect testing require individualized clinician instructions.

FAQ

Frequently asked questions

Common questions about skin prick testing

Does everyone with allergic rhinitis need SPT?

No. Clinicians consider testing when results are likely to change care — for example, clarifying triggers or unsettled history.

Does a positive result mean I must avoid that allergen completely?

Not always. Positives are interpreted with real-life symptoms. Your clinician helps prioritize practical avoidance.

Can blood specific-IgE replace skin testing?

In some situations it is an alternative or complement, especially when skin testing is unsuitable. Choice depends on clinical judgment.

How many days should I stop antihistamines before testing?

There is no single safe universal answer. Follow your clinic or doctor’s instructions and do not stop essential medicines on your own.

REFERENCES

References

Guidelines and references for education only — not a substitute for clinical care.

  1. ARIA

    Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis (2019)

    pubmed.ncbi.nlm.nih.gov/31627910/ (ARIA)

Educational information

Medical Disclaimer

This information is intended for educational purposes only and does not replace diagnosis or treatment by a qualified physician. If you have concerning symptoms, please consult an ENT specialist.

Wondering whether allergy testing is useful for you?

Talk with an ENT specialist about whether skin prick testing is indicated and likely to help your care plan.